ArticleBMC cancer2023

A real-world analysis of trametinib in combination with hydroxychloroquine or CDK4/6 inhibitor as third- or later-line therapy in metastatic pancreatic adenocarcinoma.

Hui Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.